EE354 Budget Impact Analysis of Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis in the UK

Abstract

Authors

K Chalmers L Sawyer A Sohrt S Robinson L Ryttig C Rinciog

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×